Prothena Corp Public (PRTA) Common Equity (2012 - 2026)
Prothena Corp Public (PRTA) recorded quarterly Common Equity of $312.6 million in Q1 2026, up 11.46% quarter-over-quarter from $280.5 million in Q4 2025, and down 28.57% on a YoY basis from $437.7 million in Q1 2025.
Prothena Corp Public (PRTA) Common Equity (2012 - 2026) Analysis & Trends
Prothena Corp Public's Common Equity history runs 15 years deep, the most recent figure standing at $312.6 million for Q1 2026.
- In Q1 2026, Common Equity fell 28.57% year-over-year to $312.6 million; the TTM figure through Mar 2026 stood at $312.6 million (down 28.57% YoY), while the FY2025 annual figure was $280.5 million, down 42.4% from the prior year.
- Common Equity was $312.6 million for Q1 2026 at Prothena Corp Public, up from $280.5 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $622.0 million in Q4 2022 to a low of $280.5 million in Q4 2025.
- Historically, Common Equity has averaged $470.4 million across 5 years, with a median of $486.9 million in 2024.
- The sharpest annual moves came in 2022 and 2025: Common Equity soared 87.09% in 2022, then slumped 44.8% in 2025.
- A 5-year view of Common Equity shows it stood at $622.0 million in 2022, then decreased by 9.75% to $561.4 million in 2023, then decreased by 13.26% to $486.9 million in 2024, then slumped by 42.4% to $280.5 million in 2025, then grew by 11.46% to $312.6 million in 2026.
- The last three Common Equity figures came in at $312.6 million (Q1 2026), $280.5 million (Q4 2025), and $295.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 35.63 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.42 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 13.21 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 14.38 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 11.87 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Prothena Corp Public | 479.08 Mn | 149.61 Mn | - | 312.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 312.62 Mn |
| Dec 31, 2025 | 280.47 Mn |
| Sep 30, 2025 | 294.99 Mn |
| Jun 30, 2025 | 324.33 Mn |
| Mar 31, 2025 | 437.68 Mn |
| Dec 31, 2024 | 486.93 Mn |
| Sep 30, 2024 | 534.36 Mn |
| Jun 30, 2024 | 581.92 Mn |
| Mar 31, 2024 | 502.40 Mn |
| Dec 31, 2023 | 561.37 Mn |
| Sep 30, 2023 | 617.23 Mn |
| Jun 30, 2023 | 581.68 Mn |
| Mar 31, 2023 | 607.41 Mn |
| Dec 31, 2022 | 622.04 Mn |
| Sep 30, 2022 | 404.65 Mn |
| Jun 30, 2022 | 407.30 Mn |
| Mar 31, 2022 | 438.89 Mn |
| Dec 31, 2021 | 466.04 Mn |
| Sep 30, 2021 | 490.47 Mn |
| Jun 30, 2021 | 288.21 Mn |